Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -5.45
- Piotroski Score 2.00
- Grade Neutral
- Symbol (ONCR)
- Company Oncorus, Inc.
- Price $0.12
- Changes Percentage (0%)
- Change $0.12
- Day Low $0.12
- Day High $0.12
- Year High $0.12
Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various cancers. It is also developing ONCR-GBM, a preclinical stage oHSV program for treating brain cancer through intratumoral injection; and synthetic viral immunotherapies based on Coxsackievirus A21 and Seneca Valley Virus. The company has a clinical trial collaboration and supply agreement with MSD International GmbH to evaluate the safety and tolerability of ONCR-177 combined with Merck's cancer immunotherapy KEYTRUDA in its Phase 1 clinical trial in patients with solid tumors. Oncorus, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
- Last Earnings N/A
- Ex-Dividend for 5/16 Dividend 12/26/2023
- Dividend Payable N/A
- Today N/A
- Next Earnings (Estimated) 03/22/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$3.48
- Trailing P/E Ratio -0.036206896551724
- Forward P/E Ratio -0.036206896551724
- P/E Growth -0.036206896551724
- Net Income $-78,307,000
Income Statement
Quarterly
Annual
Latest News of ONCR
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Lower carbon IBAA/R8 concrete debuts in UK construction
A new low-carbon concrete solution using Incinerator Bottom Ash Aggregate (IBAA) and Recycl8's R8 Mix has been introduced at Veolia's Ling Hall site in the UK....
By Yahoo! Finance | 14 hours ago -
Giant concrete slab outside Palestinian eatery baffles in NYC:...
A Palestinian restaurant chain, Ayat, faced backlash for anti-Israel statements on its menu and now for installing a large concrete slab on a Brooklyn sidewalk. Locals find it obstructive and unsafe, ...
By New York Post | 6 days ago -
Betolar and Saudi Readymix unveil low-carbon concrete formulations
Betolar and Saudi Readymix have collaborated to develop two low-carbon concrete formulations, aligning with Saudi Arabia's sustainability goals. These innovative mixes reduce carbon emissions signific...
By Yahoo! Finance | 1 week ago
